GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunogen Inc (NAS:IMGN) » Definitions » E10

Immunogen (Immunogen) E10 : $-1.08 (As of Sep. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Immunogen E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Immunogen's adjusted earnings per share data for the three months ended in Sep. 2023 was $0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.08 for the trailing ten years ended in Sep. 2023.

During the past 3 years, the average E10 Growth Rate was 0.30% per year. During the past 5 years, the average E10 Growth Rate was -0.20% per year. During the past 10 years, the average E10 Growth Rate was -5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Immunogen was 23.40% per year. The lowest was -13.40% per year. And the median was -5.25% per year.

As of today (2024-05-26), Immunogen's current stock price is $31.23. Immunogen's E10 for the quarter that ended in Sep. 2023 was $-1.08. Immunogen's Shiller PE Ratio of today is .


Immunogen E10 Historical Data

The historical data trend for Immunogen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunogen E10 Chart

Immunogen Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.09 -1.10 -1.04 -1.07 -1.09

Immunogen Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -1.09 -1.12 -1.10 -1.08

Competitive Comparison of Immunogen's E10

For the Biotechnology subindustry, Immunogen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunogen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunogen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Immunogen's Shiller PE Ratio falls into.



Immunogen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immunogen's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0.1/129.8595*129.8595
=0.100

Current CPI (Sep. 2023) = 129.8595.

Immunogen Quarterly Data

per share eps CPI Adj_EPS
201312 0.040 98.326 0.053
201403 -0.440 99.695 -0.573
201406 -0.310 100.560 -0.400
201409 -0.260 100.428 -0.336
201412 0.160 99.070 0.210
201503 -0.250 99.621 -0.326
201506 -0.350 100.684 -0.451
201509 -0.390 100.392 -0.504
201512 -0.380 99.792 -0.494
201603 -0.370 100.470 -0.478
201606 -0.510 101.688 -0.651
201609 -0.510 101.861 -0.650
201612 -0.400 101.863 -0.510
201703 -0.200 102.862 -0.252
201706 -0.100 103.349 -0.126
201709 -0.610 104.136 -0.761
201712 -0.110 104.011 -0.137
201803 -0.300 105.290 -0.370
201806 -0.310 106.317 -0.379
201809 -0.320 106.507 -0.390
201812 -0.280 105.998 -0.343
201903 -0.300 107.251 -0.363
201906 -0.290 108.070 -0.348
201909 -0.150 108.329 -0.180
201912 0.030 108.420 0.036
202003 -0.170 108.902 -0.203
202006 -0.140 108.767 -0.167
202009 -0.130 109.815 -0.154
202012 0.160 109.897 0.189
202103 -0.170 111.754 -0.198
202106 -0.150 114.631 -0.170
202109 -0.180 115.734 -0.202
202112 -0.170 117.630 -0.188
202203 -0.100 121.301 -0.107
202206 -0.240 125.017 -0.249
202209 -0.310 125.227 -0.321
202212 -0.230 125.222 -0.239
202303 -0.160 127.348 -0.163
202306 -0.020 128.729 -0.020
202309 0.100 129.860 0.100

Add all the adjusted EPS together and divide 10 will get our e10.


Immunogen  (NAS:IMGN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Immunogen E10 Related Terms

Thank you for viewing the detailed overview of Immunogen's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunogen (Immunogen) Business Description

Traded in Other Exchanges
Address
830 Winter Street, Waltham, MA, USA, 02451
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
Executives
Theresa Wingrove officer: VP of Regulatory Affairs IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Renee Lentini officer: V.P.-Fin., Prin. Acctg. Off. 830 WINTER STREET, WALTHAM MA 02451
Stacy Ann Coen officer: Chief Business Officer 11 RUSH POND RD, LAKEVILLE MA 02347
Kristine Peterson director AMARIN CORPORATION, MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE, MYSTIC CT 06355
Lauren White officer: SVP, CFO and PFO C4 THERAPEUTICS, INC., 490 ARSENAL WAY, SUITE 200, WATERTOWN MA 02472
Mark J Enyedy director, officer: Chief Executive Officer C/O FATE THERAPEUTICS, INC., 3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO CA 92121
Isabel Kalofonos officer: SVP & CHIEF COMMERCIAL OFFICER C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Michael Vasconcelles officer: EVP R&D & MEDICAL AFFAIRS C/O UNUM THERAPEUTICS, 200 CAMBRIDGEPARK DR., STE. 3100, CAMBRIDGE MA 02140
Daniel Char officer: SVP & CHIEF LEGAL OFFICER C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139
Kristen Harrington-smith officer: SVP & Chief Commercial Officer C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Tracey L Mccain director C/O BLUEPRINTS MEDICINES CORPORATION, 38 SIDNEY STREET, SUITE 200, CAMBRIDGE MA 02139
Helen M. Thackray director C/O GLYCOMIMETICS, INC., 401 PROFESSIONAL DRIVE, SUITE 250, GAITHERSBURG MD 20879
David G Foster officer: V.P.-Fin., Prin. Acctg. Off. C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451
Susan Altschuller officer: SVP and CFO 45 TENNYSON ST., SOMERVILLE MA 02145
Craig Barrows officer: Vice-President,General Counsel C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451

Immunogen (Immunogen) Headlines

From GuruFocus